APA (7th ed.) Citation

Jittikoon, J., Saengsiwaritt, W., Chanhom, N., Chaikledkaew, U., Wattanapokayakit, S., Mahasirimongkol, S., & Udomsinprasert, W. (2025). Association of NAT2 promoter hypermethylation with susceptibility to hepatotoxicity due to antituberculosis drugs and biomarker potential. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-95050-6

Chicago Style (17th ed.) Citation

Jittikoon, Jiraphun, Wacharapol Saengsiwaritt, Noppadol Chanhom, Usa Chaikledkaew, Sukanya Wattanapokayakit, Surakameth Mahasirimongkol, and Wanvisa Udomsinprasert. "Association of NAT2 Promoter Hypermethylation with Susceptibility to Hepatotoxicity Due to Antituberculosis Drugs and Biomarker Potential." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-95050-6.

MLA (9th ed.) Citation

Jittikoon, Jiraphun, et al. "Association of NAT2 Promoter Hypermethylation with Susceptibility to Hepatotoxicity Due to Antituberculosis Drugs and Biomarker Potential." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-95050-6.